ELV vs UNH
Elevance Health, Inc. and UnitedHealth Group Incorporated, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | ELV | UNH |
|---|---|---|
| Revenue | $199.1B | $447.6B |
| Net income | $5.7B | $12.1B |
| Gross margin | 89.4% | 88.7% |
| Net margin | 2.8% | 2.7% |
| Return on equity | 13.3% | 17.9% |
| Diluted EPS | $25.21 | $13.23 |
| Dividend / share | $5.92 | $8.73 |
| Payout ratio | 27.0% | 65.7% |
| Free cash flow | $3.2B | $16.1B |
| Equity | $43.9B | $32.5B |
| Net debt / equity | 0.51× | 0.31× |
| Current ratio | 1.54× | 0.79× |
| Revenue CAGR 5y | 10.3% | 11.7% |
| Profit CAGR 5y | 4.4% | −4.8% |
UNH bills 2.2× the revenue of ELV, and ELV keeps more of each dollar of revenue as profit (2.8% against 2.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | ELV | UNH |
|---|---|---|
| FY2025 | $199.1B | $447.6B |
| FY2024 | $177.0B | $400.3B |
| FY2023 | $171.3B | $371.6B |
| FY2022 | $156.6B | $324.2B |
| FY2021 | $138.6B | $287.6B |
| FY2020 | $121.9B | $257.1B |
| FY2019 | $104.2B | $242.2B |
| FY2018 | $92.1B | $226.2B |
| FY2017 | $90.0B | $201.2B |
| FY2016 | $84.9B | $184.8B |
Net income by year
Bottom line
| Fiscal year | ELV | UNH |
|---|---|---|
| FY2025 | $5.7B | $12.1B |
| FY2024 | $6.0B | $14.4B |
| FY2023 | $6.0B | $22.4B |
| FY2022 | $5.9B | $20.1B |
| FY2021 | $6.2B | $17.3B |
| FY2020 | $4.6B | $15.4B |
| FY2019 | $4.8B | $13.8B |
| FY2018 | $3.8B | $12.0B |
| FY2017 | $3.8B | $10.6B |
| FY2016 | $2.5B | $7.0B |
Advertisement
AdSense · Rectangle 336×280